Other markets

As a multinational BioPharma company, we operate either directly or through distributor partners in many countries.  For contact information in the countries where Bristol Myers Squibb does not have a local office please contact our third party business partners from the drop-down menu.


Bosnia and Herzegovina

Amicus Pharma d.o.o.
Fra Anđela Zvizdovića 1
71000 Sarajevo
Tel. +387 33 257 810
bih.info@swixxbiopharma.com

Transparency Documents

EFPIA 2021
Methodology Document 2021

Bulgaria

Swixx Biopharma EOOD
Sterling Serviced Office Group
48 Sitnyakovo Blvd.
Serdika center – 10th floor
Serdika Mall
1505 Sofia
Tel. +359 2 4942 480

bulgaria.info@swixxbiopharma.com

Transparency Documents

EFPIA 2022
Methodology Document 2022

EFPIA 2021
Methodology Document 2021

EFPIA 2020
Methodology Document 2020

Croatia

Swixx Biopharma d.o.o.
Savska 32
10000 Zagreb
Tel. +385 1 2078 500 Tel. +385 1 2078 508
croatia.info@swixxbiopharma.com

Transparency Documents

EFPIA 2022
Methodology Document 2022

EFPIA 2021
Methodology Document 2021

EFPIA 2020
Methodology Document 2020

Estonia

Swixx Biopharma OÜ
Tornimäe 5 – 2
10145 Tallinn
Tel. +372 640 1030

estonia.info@swixxbiopharma.com

Transparency Documents

EFPIA 2022
Methodology Document 2022

EFPIA 2021
Methodology Document 2021

EFPIA 2020
Methodology Document 2020

Egypt

Fattal Office/Medscience
48 Elhoreya St., Almaza, Heliopolis,
6th floor, Flat 12. Cairo-Egypt

Telephone: +20224146784

Iceland

VISTOR
Horgatun 2
210 Gardabear, Island

http://vistor.is

Transparency Documents

EFPIA 2021
Methodology Document 2021

Israel

Bristol Myers Squibb Israel
18 Aharon Bart St, PO BOX 3361,
Kiryat Arye, Petah Tikva
4951448, Israel

Telephone: +972-3-5231021

Jordan

Orient Drug Store
P.O. Box 590, Nimer El Edwan St.
Jabal El Weibdeh El Gharbi, Amman 11118-Jordan

Telephone: +96 26 465 2000

Latvia

Swixx BioPharma SIA
Valdemara iela 33 – 18A
Riga, LV-1010
Tel. +371 67708347
latvia.info@swixxbiopharma.com

Transparency Documents

EFPIA 2022
Methodology Document 2022

EFPIA 2021
Methodology Document 2021

EFPIA 2020
Methodology Document 2020

Lebanon

Pacific Pharma
Hussein Oueyni st, Ras Beirut, Beirut, Lebanon

Telephone: +961-1-806640 | +961-1-788976
Email: pacific@terra.net.lb

Lithuania

Swixx Biopharma UAB
Bokšto 1-3
Vilnius
Tel. +370 5 236 9140
lithuania.info@swixxbiopharma.com

Transparency Documents

EFPIA 2022
Methodology Document 2022

EFPIA 2021
Methodology Document 2021

EFPIA 2020
Methodology Document 2020

Malta

A.M. Mangion Ltd.
Mangion Building,
N/S off Valletta Road,
Luqa, LQA 6000, Malta

http://ammangion.com.mt

Transparency Documents

EFPIA 2022
Methodology Document 2022

EFPIA 2021
Methodology Document 2021

EFPIA 2020
Methodology Document 2020

Russia


BMS Transparency Documents

EFPIA 2022   
Methodology   Report

EFPIA 2021   
Methodology   Report

EFPIA 2020   
Methodology   Report


Celgene Transparency Documents

EFPIA 2020   
Methodology Report

Serbia

Amicus SRB d.o.o.
Milorada Jovanovica
911000 Belgrade
Tel. +381 11 4426 300 Tel. +381 11 4426 301
serbia.info@swixxbiopharma.com

Transparency Documents

EFPIA 2022
Methodology Document 2022

EFPIA 2021
Methodology Document 2021

EFPIA 2020
Methodology Document 2020

Slovakia

Swixx Biopharma s. r. o.
Regus Apollo Business Centre
Prievozská 4D, Blok E
Bratislava 821 09
Tel. +421 2 20833 600
slovakia.info@swixxbiopharma.com

Transparency Documents

EFPIA 2022
Methodology Document 2022

EFPIA 2021
Methodology Document 2021

EFPIA 2020
Methodology Document 2020

Slovenia

Swixx Biopharma d.o.o.
Pot k sejmišču
351231 Ljubljana – Črnuče
Tel. +386 1 2355 100
slovenia.info@swixxbiopharma.com

Transparency Documents

EFPIA 2022
Methodology Document 2022

EFPIA 2021
Methodology Document 2021

EFPIA 2020
Methodology Document 2020

Ukraine

 

Transparency Documents

EFPIA 2021
Methodology Document 2021

Venezuela

 

DROVITAL CASA DE REPRESENTACIÓN, C.A.
Oficina A, Planta Intermedia, Torre Financiera, Avenida Beethoven, Urbanización Colinas de Bello Monte,
Municipio Baruta, área metropolitana de Caracas, Venezuela.
+58 (212) 751 3202
blanca.berrios@drovitalcr.com